Discover how the LumiraDx Platform has helped a community pharmacy evolve its point-of-care testing

12 Oct 2022
Discover how the LumiraDx Platform has helped a community pharmacy evolve its point-of-care testing

In this video, Niamh Boden, Dunville Community Pharmacy, discusses how the COVID-19 pandemic has evolved how pharmacies offer accessible community care and why she chose the LumiraDx Platform for point-of-care diagnostic testing.

About the company

LumiraDx logo

LumiraDx

LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. Our technology provides fast, high performance and accessible diagnostic solutions at the point of need.

LumiraDx Platform

LumiraDx

Next-generation point of care diagnostic platform - Next-generation microfluidic technology on the LumiraDx Platform enables lab-comparable performance across a broad menu of diagnostic assays.

(0)

Other videos from LumiraDx

Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.
Discover how the LumiraDx Platform has helped a community pharmacy evolve its point-of-care testing